The current state of omics technologies in the clinical management of asthma and allergic diseases.


Journal

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
ISSN: 1534-4436
Titre abrégé: Ann Allergy Asthma Immunol
Pays: United States
ID NLM: 9503580

Informations de publication

Date de publication:
12 2019
Historique:
received: 11 07 2019
revised: 27 08 2019
accepted: 29 08 2019
pubmed: 9 9 2019
medline: 10 3 2020
entrez: 9 9 2019
Statut: ppublish

Résumé

To review the state of omics science specific to asthma and allergic diseases and discuss the current and potential applicability of omics in clinical disease prediction, treatment, and management. Studies and reviews focused on the use of omics technologies in asthma and allergic disease research and clinical management were identified using PubMed. Publications were included based on relevance, with emphasis placed on the most recent findings. Omics-based research is increasingly being used to differentiate asthma and allergic disease subtypes, identify biomarkers and pathological mediators, predict patient responsiveness to specific therapies, and monitor disease control. Although most studies have focused on genomics and transcriptomics approaches, increasing attention is being placed on omics technologies that assess the effect of environmental exposures on disease initiation and progression. Studies using omics data to identify biological targets and pathways involved in asthma and allergic disease pathogenesis have primarily focused on a specific omics subtype, providing only a partial view of the disease process. Although omics technologies have advanced our understanding of the molecular mechanisms underlying asthma and allergic disease pathology, omics testing for these diseases are not standard of care at this point. Several important factors need to be addressed before these technologies can be used effectively in clinical practice. Use of clinical decision support systems and integration of these systems within electronic medical records will become increasingly important as omics technologies become more widely used in the clinical setting.

Identifiants

pubmed: 31494234
pii: S1081-1206(19)31049-X
doi: 10.1016/j.anai.2019.08.460
pmc: PMC6931133
mid: NIHMS1543658
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

550-557

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD043483
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI077930
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL087738
Pays : United States

Informations de copyright

Copyright © 2019 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Références

Int J Epidemiol. 2012 Feb;41(1):24-32
pubmed: 22296988
Front Immunol. 2018 Jul 17;9:1584
pubmed: 30065721
Genet Med. 2013 Oct;15(10):761-71
pubmed: 23743551
BMJ Open. 2018 Sep 10;8(9):e021311
pubmed: 30206078
Respir Res. 2017 Aug 3;18(1):149
pubmed: 28774304
J Intern Med. 2016 Mar;279(3):229-40
pubmed: 26891944
Genome Biol. 2017 May 5;18(1):83
pubmed: 28476144
Expert Rev Proteomics. 2011 Apr;8(2):221-30
pubmed: 21501015
Curr Opin Allergy Clin Immunol. 2016 Oct;16(5):469-76
pubmed: 27490125
Science. 2018 Mar 16;359(6381):1233-1239
pubmed: 29590070
Pediatr Pulmonol. 2018 Jun;53(6):836-845
pubmed: 29493882
J Allergy Clin Immunol. 2018 Sep;142(3):991-993.e3
pubmed: 29787780
Curr Allergy Asthma Rep. 2017 Aug 10;17(9):62
pubmed: 28812256
Ann Allergy Asthma Immunol. 2019 Mar;122(3):270-275
pubmed: 30552986
Nat Rev Genet. 2018 May;19(5):299-310
pubmed: 29479082
Epigenomics. 2017 Apr;9(4):539-571
pubmed: 28322581
Respir Res. 2019 Jun 10;20(1):115
pubmed: 31182091
Ann Allergy Asthma Immunol. 2019 Feb;122(2):208-210
pubmed: 30448624
BMC Med Inform Decis Mak. 2017 Jul 6;17(1):100
pubmed: 28683736
Am J Respir Cell Mol Biol. 2017 Oct;57(4):439-447
pubmed: 28574721
Gigascience. 2017 Oct 1;6(10):1-11
pubmed: 29046044
Curr Opin Pulm Med. 2017 Jan;23(1):12-20
pubmed: 27764000
Genet Med. 2013 Oct;15(10):772-8
pubmed: 24071798
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S81-94
pubmed: 20176270
Clin Chem. 2017 Jul;63(7):1299-1300
pubmed: 28515101
Immunol Allergy Clin North Am. 2015 Feb;35(1):19-44
pubmed: 25459575
Annu Rev Genomics Hum Genet. 2016 Aug 31;17:353-73
pubmed: 27147087
Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):435-9
pubmed: 26258923
J Allergy Clin Immunol. 2018 Apr;141(4):1191-1201
pubmed: 28479327
Am J Respir Crit Care Med. 2016 Jan 1;193(1):98-100
pubmed: 26720789
Curr Allergy Asthma Rep. 2016 Jul;16(7):48
pubmed: 27333777
Allergy. 2019 Mar;74(3):449-463
pubmed: 30515837
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Asthma Res Pract. 2018 Jan 5;4:1
pubmed: 29318023
Environ Health Perspect. 2004 May;112(7):A410-5
pubmed: 15159214
Front Med (Lausanne). 2019 Mar 01;6:34
pubmed: 30881956
Front Genet. 2014 Nov 18;5:401
pubmed: 25477900
OMICS. 2015 Apr;19(4):197-208
pubmed: 25831060
Pulm Pharmacol Ther. 2010 Dec;23(6):468-81
pubmed: 20601050
Front Immunol. 2018 Dec 12;9:2727
pubmed: 30631320
Immunol Rev. 2011 Jul;242(1):10-30
pubmed: 21682736
Chest. 2017 Feb;151(2):262-277
pubmed: 27776981
OMICS. 2018 Jun;22(6):392-409
pubmed: 29927718
J Allergy Clin Immunol. 2014 Feb;133(2):500-10
pubmed: 24636474
J Allergy Clin Immunol. 2017 Feb;139(2):388-399
pubmed: 28183433
Nucleic Acids Res. 2017 Jan 4;45(D1):D979-D984
pubmed: 27924041
J Breath Res. 2019 May 08;13(3):036009
pubmed: 30213921
Eur Respir Rev. 2018 Feb 7;27(147):
pubmed: 29436404
Rev Environ Health. 2017 Mar 1;32(1-2):45-54
pubmed: 27768585
Clin Epigenetics. 2016 Aug 12;8:86
pubmed: 27525046
Front Med (Lausanne). 2017 Sep 26;4:158
pubmed: 29018800
Rev Environ Health. 2017 Mar 1;32(1-2):55-63
pubmed: 28170342
PLoS One. 2019 Apr 12;14(4):e0215026
pubmed: 30978214
Nat Immunol. 2019 May;20(5):637-651
pubmed: 30962590
Neuroscience. 2009 Nov 24;164(1):30-42
pubmed: 19344640
Cell. 2012 Mar 16;148(6):1293-307
pubmed: 22424236
IEEE Trans Biomed Eng. 2017 Feb;64(2):263-273
pubmed: 27740470
Clin Transl Med. 2018 Jan 26;7(1):4
pubmed: 29374337
Int J Mol Sci. 2016 Sep 14;17(9):
pubmed: 27649151
Nat Commun. 2018 Oct 16;9(1):4285
pubmed: 30327483
Allergy. 2019 Nov;74(11):2129-2145
pubmed: 31004501
Front Pediatr. 2019 Feb 05;7:6
pubmed: 30805318
J Allergy Clin Immunol. 2015 May;135(5):1319-28.e1-12
pubmed: 25678091
Ann N Y Acad Sci. 2018 Jan;1411(1):140-152
pubmed: 29377200
Int Arch Allergy Immunol. 2018;177(4):324-333
pubmed: 30399611
Clin Exp Allergy. 2015 Jan;45(1):21-31
pubmed: 24766371
Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):142-151
pubmed: 27576363
J Allergy Clin Immunol. 2018 Sep;142(3):715-726
pubmed: 30195377
Biomed Res Int. 2018 Jun 11;2018:4617565
pubmed: 29992143

Auteurs

Brittney M Donovan (BM)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Lisa Bastarache (L)

Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.

Kedir N Turi (KN)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Mary M Zutter (MM)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.

Tina V Hartert (TV)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: tina.hartert@vumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH